Indegene Limited (INDGN.NS)

INR 612.15

(1.68%)

EBITDA Summary of Indegene Limited

  • Indegene Limited's latest annual EBITDA in 2023 was 4.85 Billion INR , up 10.48% from previous year.
  • Indegene Limited's latest quarterly EBITDA in 2024 Q2 was 1.47 Billion INR , down -2.58% from previous quarter.
  • Indegene Limited reported an annual EBITDA of 4.54 Billion INR in 2022, up 43.08% from previous year.
  • Indegene Limited reported an annual EBITDA of 2.65 Billion INR in 2021, up 17.93% from previous year.
  • Indegene Limited reported a quarterly EBITDA of 1.47 Billion INR for 2024 Q2, down -2.58% from previous quarter.
  • Indegene Limited reported a quarterly EBITDA of 1.25 Billion INR for 2023 Q1, up 17.93% from previous quarter.

Annual EBITDA Chart of Indegene Limited (2023 - 2019)

Historical Annual EBITDA of Indegene Limited (2023 - 2019)

Year EBITDA EBITDA Growth
2023 4.85 Billion INR 10.48%
2022 4.54 Billion INR 43.08%
2021 2.65 Billion INR 17.93%
2020 2.6 Billion INR 94.33%
2019 1.33 Billion INR 0.0%

Peer EBITDA Comparison of Indegene Limited

Name EBITDA EBITDA Difference
Brookfield India RET -8.02 Billion INR 160.51%
EMBASSY OFFICE PAR 29.02 Billion INR 83.283%
Entero Healthcare Solutions Limited 1.26 Billion INR -284.838%
Gloster Limited 785.47 Million INR -517.844%
GPT Healthcare Limited 925.19 Million INR -424.536%
India Shelter Finance Corporation Limited 6.18 Billion INR 21.55%
Jupiter Life Line Hospitals Limited 2.64 Billion INR -83.73%
Medi Assist Health Ser L 1.3 Billion INR -271.519%
Rashi Peripherals Limited 3.21 Billion INR -50.982%
Shipping Corporation of India Land and Assets Limited 558 Million INR -769.713%
SRG Housing Finance Limited 329.72 Million INR -1371.833%
Yatharth Hospital & Trauma Care Services Limited 1.97 Billion INR -145.674%